Sisram Medical (1696.HK) Stock Price
Sisram Medical Price
Over the last 11 years Sisram Medical grew revenue by 12.4% annually, reaching 365.35 M USD. Earnings per share have grown at 11.2% per year over the last 11 years. For Sisram Medical, the net margin of 5.2% is down versus 10.6% a few years ago. At today's price the dividend yield works out to roughly 0.56%. The payout ratio is around 0% of earnings. The consensus 12-month price target for Sisram Medical is 0.78 USD, about 243.8% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Sisram Medical stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sisram Medical business model & stock analysis
Frequently asked questions about Sisram Medical
Sisram Medical Ltd operates through a business model focused on the development, manufacturing, and distribution of energy-based aesthetic medical and cosmetic devices. As a leading global provider, Sisram Medical offers a wide range of products designed to enhance procedures like hair removal, wrinkle reduction, body contouring, and skin rejuvenation. By leveraging their expertise in advanced technologies and medical aesthetics, Sisram Medical aims to cater to the growing demand for non-invasive and minimally invasive aesthetic procedures. With a strong commitment to innovation and customer satisfaction, Sisram Medical Ltd continues to strive in the aesthetic medical industry.
Sisram Medical Ltd is primarily active in the healthcare and medical device industries.
The main competitors of Sisram Medical Ltd in the market include leading players in the medical aesthetics industry such as Syneron Medical Ltd and Cutera Inc. These companies also specialize in providing a wide range of innovative and advanced aesthetic medical devices and solutions. However, Sisram Medical Ltd sets itself apart through its unique offerings and cutting-edge technologies that cater to the specific needs of its customers. With its strong market presence and commitment to excellence, Sisram Medical Ltd continues to establish itself as a formidable competitor in the medical aesthetics market.
Sisram Medical Ltd is a leading global provider of energy-based aesthetic medical and minimally invasive surgical devices. Founded in 2000, the company has established a strong presence in the medical aesthetics market. Sisram Medical offers a wide range of innovative products and solutions designed to enhance beauty, improve health, and promote well-being. With a strong focus on research and development, Sisram Medical continuously strives to deliver cutting-edge technologies and advanced treatment options to its customers. The company has achieved significant growth and success over the years, and its commitment to excellence has made it a trusted name in the medical aesthetics industry.
Sisram Medical Ltd has achieved several significant milestones in its journey. The company has successfully established itself as a global leader in the field of medical aesthetics and energy-based devices. Sisram Medical Ltd has continuously advanced its product portfolio, introducing innovative technologies and solutions for various medical and cosmetic procedures. With a strong focus on research and development, the company has received numerous accolades for its breakthrough products and cutting-edge technologies. Sisram Medical Ltd has also expanded its global presence, establishing strategic partnerships and collaborations to strengthen its market position. Overall, Sisram Medical Ltd has an impressive track record of achievements, cementing its reputation as a trusted and progressive player in the healthcare industry.
Sisram Medical Ltd is primarily present in multiple countries and regions worldwide. The company has a strong global presence and operates in various markets, including the United States, China, Europe, and Asia-Pacific. With its commitment to innovation and advanced medical technologies, Sisram Medical Ltd has successfully established a widespread presence in key healthcare markets around the globe.
Sisram Medical Ltd represents values of innovation, integrity, and excellence in the medical industry. As a leading global provider of comprehensive medical aesthetic solutions, the company is committed to enhancing people's lives through advanced technologies and high-quality products. Sisram Medical Ltd prioritizes customer satisfaction and remains dedicated to delivering state-of-the-art solutions while upholding the highest ethical standards. With a strong focus on research and development, Sisram Medical Ltd continuously strives to pioneer advancements in medical aesthetics, ultimately leading to improved patient outcomes and increased market value.
Analysts currently set an average price target of 0.78 USD for the Sisram Medical stock (median: 0.78 USD), implying +243.8 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Sisram Medical stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sisram Medical to generate revenue of 407.47 M USD and earnings per share of 0.09 USD.
Converted at the current exchange rate, the Sisram Medical share trades at 0.20 EUR (0.23 USD).
The Sisram Medical share (1696.HK) is listed on 1 stock exchanges, including: Hongkong (HKEX) (1696.HK).
Sisram Medical is an international provider of high-tech medical technology, offering a wide range of innovative high-end products for use in aesthetic medicine and ophthalmic surgery. The company operates in three different business areas: aesthetic medicine, ophthalmology, and products for medical facilities. In the field of aesthetic medicine, the company offers various treatment options, including laser hair removal devices, ultrasound focus devices, and non-invasive skin tightening devices, among others. Sisram Medical is a joint venture between Chinese company Fosun Pharma and Israeli company Syneron Candela, founded in 2017. The company is headquartered in Yokneam, Israel, and has a presence in Europe, Asia, and the USA. In the field of ophthalmology, Sisram Medical offers lasers and accessories for various applications, including LASIK eye surgery and photodynamic therapy. The company also offers products for medical facilities with different focuses, such as patient monitoring systems, infusion systems, or medical sterilization devices. Sisram Medical aims to supply the market with innovative technologies and highest quality products. The company has established itself in the market primarily through its high innovation power and close collaboration with medical research institutions. Over the past years, Sisram Medical has successfully acquired numerous medium-sized companies in Europe and Asia to strengthen its presence in these markets. In the USA, the company is now one of the leading providers of medical laser devices. The company has further plans for the coming months and years to expand and deepen its business. Vertical integration and driving its own research and development projects are expected to play a central role. In terms of SEO optimization, for example, the names of the various laser devices or treatment options could be linked in the text to achieve better Google rankings. In summary, Sisram Medical Ltd offers a wide range of innovative medical technology products for use in the fields of aesthetic medicine, ophthalmology, and medical facilities. The company has many years of experience in the industry and a broad customer base. In the future, the focus will be on vertical integration and in-house research and development to establish itself as a market leader through even more innovative products.
The expected revenue of Sisram Medical is 407.47 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sisram Medical is 40.06 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sisram Medical is currently 2.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sisram Medical stock.
The price-to-sales ratio (P/S) of Sisram Medical is currently 0.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sisram Medical stock.
The Eulerpool Quality Score for Sisram Medical is 4/10.
The ISIN of Sisram Medical is IL0011418113. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sisram Medical is 1696.HK. The ticker symbol is used to trade Sisram Medical shares on the stock exchange.
Sisram Medical stock
Sisram Medical Peer Group
Sisram Medical Ticker
Sisram Medical FIGI
All fundamentals and in-depth analysis of Sisram Medical
Our stock analysis for Sisram Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sisram Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.